Deletion of the short arm of chromosome 3 in breast tumors

Genes Chromosomes and Cancer

Volumn 18, Issue 4, 1997, Pages 241-245

  Pandis, Nikos ^a,b   Bardi, Georgia ^a,b   Mitelman, Felix ^a   Heim, Sverre ^a,c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b SAINT SAVVAS HOSPITAL   (Greece)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; BENIGN TUMOR; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST TUMOR; CHROMOSOME 3P; FAMILIAL CANCER; HETEROZYGOSITY LOSS; HUMAN; INTERSTITIAL CHROMOSOME DELETION; MOLECULAR GENETICS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; HUMANS;

EID: 0030894455     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199704)18:4<241::AID-GCC1>3.0.CO;2-0     Document Type: Article

References (39)

1. Ali IU, Lidereau R, Callahan R (1989) Presence of two members of c-erb A receptor gene family (c-erbaß and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma. J Natl Cancer Inst 81:1815-1820.
2. Bergthorsson JT, Eiriksdottir G, Barkardottir RB, Egilsson Y, Arason A, Ingvarsson S (1995) Linkage analysis and allelic imbalance in human breast cancer kindreds using microsatellite markers from the short arm of chromosome 3. Hum Genet 96:437-443.
3. Bièche I, Lidereau R (1995) Generic alterations in breast cancer. Genes Chromosom Cancer 14:227-251.
4. Huchhagen DL, Qiu L, Etkind P (1994) Homozygous deletion, rearrangement and hypemethylation implicate chromosome region 3p14.3-3p21.3 in sporadic breast cancer development. Int J Cancer 57:473-479.
5. Chen L-C, Matsumura K, Deng G, Kurisu W, Ljung B-M, Lerman MI, Waldman FM, Smith HS (1994) Deletion of two separate regions on chromosome 3p in breast cancers. Cancer Res 54:3021-3024.
6. Cornelisse CJ, Kuipers-Dijkshoorn N, van Vliet M, Herman J, Devilee P (1992) Fractional allelic imbalance in human breast cancer increases with tetraploidization and chromosome loss. Int J Cancer 50:544-548.
7. Devilee P, van den Broek M, Kuipers-Dijkshoorn N, Kolluri R, Khan PM, Pearson PL, Cornelisse CJ (1989) At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics 5:554-560.
8. Dietrich CU, Pandis N, Teixeira MR, Bardi G, Gerdes A-M, Andersen JA, Heim S (1995a) Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue. Int J Cancer 60:49-53.
9. Dietrich CU, Pandis N, Bardi G, Hägerstrand I, Andersen JA, Mitelman F, Heim S (1995b) Rearrangement of chromosomal hands 3p13-14 in two hamartomas of the breast. Int J Oncol 6:559-561.
10. Ehlen T, Dubeau L (1990) Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas. Oncogene 5:219-223.
11. Eiriksdottir G, Bergthorsson JT, Sigurdsson H, Gudmundsson J, Skirnisdottir S, Egilsson V, Barkadottir RB, Ingvarsson S (1995) Mapping of chromosome 3 alterations in human breast cancer using microsatellite PCR markers: Correlation with clinical variables. Int J Oncol 6:369-375.
12. Heim S, Mitelman F (1995) Cancer Cytogenetics, 2nd Ed. New York: Wiley-Liss.
13. Kastury K, Baffa R, Druck T, Ohta M, Cotticelli MG, Inoue H, Negrini M, Rugge M, Huang D, Croce CM, Palazzo J, Huebner K (1996) Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res 56:978-983.
14. Latif F, Fivash M, Glenn G, Tory K, Orcutt ML, Hampsch K, Delisio J, Lerman M, Cowan J, Beckett M, Weichselbaum R (1992) Chromosome 3p deletions in head and neck carcinomas: Statistical ascertainment of allelic loss. Cancet Res 52:1451-1456.
15. Le Beau MM, Rowley JD (1984) Heritable fragile sites and cancer. Nature 308:607-608.
16. Lothe RA, Fosså SD, Stenwig AE, Nakamura Y, White R, Börresen AL, Brögger A (1989) Loss of 3p or 11p alleles is associated with testicular cancer tumors. Genomics 5:134-138.
17. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennet LM, Ding W, Bell R, Rosenthal J, Hussey C, Tan T, Mclure M, Frye C, Hattier T, Phelps R, Hangen-Strano A, Katcer H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayanath P, Ward J, Tonin P, Narod S, Bristovv PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
18. Mitelman F (1994) Catalog of Chromosome Aberrations in Cancer, 5th Ed. New York: Wiley-Liss.
19. Naylor SL, Johnson BE, Minna JD, Sakaguchi AY (1987) Loss of heterozygosity of chromosome 3p markers in small-cell king cancer. Nature 329:451-153.
20. Negrini M, Monaco C, Verechovsky I, Ohta M, Druck T, Baffa R, Huebner K, Croce CM (1996) The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 56:3173-3179.
21. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K (1996) The human FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated translocation breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597.
22. Pandis N, Heim S, Bardi G, Idvall I, Mandahl N, Mitelman F (1993a) Chromosome analysis of 20 breast carcinomas: Cytogenetic multi-clonality and karyotypic-pathologic correlations. Genes Chromosom Cancer 6:51-57.
23. Pandis N, Jin Y, Limon J, Bardi G, Idvall I, Mandahl N, Mitelman F, Heim S (1993b) Interstitial deletion of the short arm of chromosome 3 as a primary chromosome abnormality in carcinomas of the breast. Genes Chromosom Cancer 6:151-155.
24. Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, Johansson B, Ingvar C, Mandahl N, Mitelman F, Heim S (1995a) Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups. Genes Chromosom Cancer 12:173-185.
25. Pandis N, Teixeira MR, Gerdes A-M, Limon J, Bardi G, Andersen JA, Idvall I, Mandahl N, Mitelman F, Heim S (1995b) Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors. Cancer 76:250-258.
26. Pennisi E (1996) New gene forges link between fragile site and many cancers. Science 272:644.
27. Petersson C, Pandis N, Mertens F, Adeyinka A, Ingvar C, Ringberg A, Idvall I, Bondeson L, Borg Å, Olsson H, Kristoffersson U, Mitelman F (1996) Chromosome aberrations in prophylactic mastectomies from women belonging to breast cancer families. Genes Chromosom Cancer. 16:185-188.
28. Petersson C., Pandis N, Rizou H, Mertens F, Dietrich CU, Adeyinka A, Idvall I, Bondeson L, Georgiou G, Ingvar C, Heim S, Mitelman F (1997) Karyotypic abnormalities in fibroadenomas of the breast. Int J Cancer. In press.
29. Sandberg AA (1993) Chromosome changes in leukemia and cancer and their molecular limning. In I.R. Kirsch (ed): The Causes and Consequences of Chromosomal Aberrations. New York: CRC Press, pp. 141-163.
30. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura V (1991) Accumulation of genetics alterations and progression of primary breast cancer. Cancer Res 51:5794-5799.
31. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti MA, Ohta M, Huebner K, Croce CM (1996) The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 85:1-20.
32. Sutherland GR (1991) Chromosomal fragile sites. Genet Anal Tech Appl 8:1616-1666.
33. Teixeira MR, Pandis N, Bardi G, Andersen JA, Heim S (1996a) Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res 56:855-859.
34. Teixeira MR, Pandis N, Gerdes A-M, Dietrich CU, Bardi G, Andersen JA, Graversen HP, Mitelman F, Heim S (1996b) Cytogenetic abnormalities in an in situ ductal carcinoma and five prophylactically removed breasts from members of a family with hereditary breast cancer. Breast Cancer Res Treat 38:177-182.
35. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Jonathan M, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Sandeep P, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir RS, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MS (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792.
36. Yokota J, Tsukada Y, Nakajima T, Gotoh M, Shimosato Y, Mori N, Tsunokawa Y, Sugimura T, Terada M (1989) Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res 49:3598-3601.
37. Yunis JJ, Soreng AL (1984) Constitutive fragile sites and cancer. Science 226:1199-1204.
38. Zbar B, Brauch H, Talmadge C, Linehan M (1987) Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 327:721-724.
39. Zhang R, Wiley J, Howard SP, Meisner LF, Gould M (1989) Rare clonal karyotypic variants in primary cultures of human breast carcinoma cells. Cancer Res 49:444-149.